Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Jounce gets $56m infusion to develop cancer immunotherapy programs

By , Globe Staff

The funding will help develop medicines that take different approaches to using the body’s immune system to combat cancers.

In cancer fight, Novartis focuses on immunity

By , Globe Staff

Novartis AG is making a big bet on emerging science that uses the body’s immune system to fight off tumors.

Vertex chief’s compensation totaled $36.6 million last year

By , Globe Staff

Compensation for Vertex Pharmaceuticals’s CEO included a one-time retention award valued at $14.9 million.

First generic drug for multiple sclerosis approved

By , Globe Staff

The move could drop the price of the drug for consumers and boost the business of Momenta Pharmaceuticals Inc.